Bookmark and Share

Compound Summary for: CID 156414

Canertinib

Also known as: 267243-28-7; CI-1033; PD183805; UNII-C78W1K5ASF; CHEBI:61399; NCGC00182713-01; S1019_Selleck
Molecular Formula: C24H25ClFN5O3   Molecular Weight: 485.938403   InChIKey: OMZCMEYTWSXEPZ-UHFFFAOYSA-N
CI-1033 is a pan-erbB tyrosine kinase inhibitor which work against esophageal squamous cell carcinoma in vitro and in vivo. CI-1033 treatment significantly affects tumour metabolism, proliferation and hypoxia as determined by PET.    From: DrugBank
Show subcontent titlesTable of Contents
Identification
Related Records
show all 3 sub-sections (Related Compounds with Annotation, Related Compounds, Related Substances)
Literature
Patents
Biomolecular Interactions and Pathways
Biological Test Results
Classification
Chemical and Physical Properties
_ _